FDA Approves Eliquis for Treatment of Deep Vein Thrombosis and Pulmonary Embolism

The US Food and Drug Administration (FDA) has approved Supplemental New Drug Application (sNDA) for Eliquis (apixaban) to treat deep vein thrombosis (DVT), formation of a blood clot in a deep vein, and pulmonary embolism (PE), caused by blood clots that go from legs to the lungs. Pfizer Inc. and... read more

Achillion Pharmaceuticals achieves success in Mid-Stage Trial of Experimental Hepatitis C Drug

Achillion Pharmaceuticals Inc has achieved success in mid-stage trial of its experimental hepatitis C drug, ACH-3102. The medicine belongs to a new class of drugs that works by blocking the NS5A protein required by the virus to replicate.

The trial was carried out in 12 patients. The drug... read more

FDA Gives Green Signal to Biogen’s MS Drug, Plegridy

On Friday, the Food and Drug Administration gave green signal to Biogen Idec to market its new injectable drug meant for adults having multiple sclerosis.

The federal regulators have approved the drug called Plegridy as a longer lasting treatment for patients suffering from relapsing-... read more

Pfizer to Pay $35 Million to Settle Issue of Promoting a Drug for Unapproved Uses

Pfizer will have to shell out $35 million to settle the issue of illegally marketing an organ transplant drug for unapproved uses. The pharmaceutical company faced allegations from 42 states, including Mississippi, after its Wyeth Pharmaceuticals reportedly breached drug marketing policies.... read more

New Drug could significantly Cut Cholesterol

A drug has been claimed to have great potential of cutting cholesterol. The drug has been developed by Sanofi SA and Regeneron Pharmaceuticals Inc. and it has yielded successful results in nine late-stage clinical trials.

Alirocumab is an injectible drug and belongs to a new class of... read more

Roche Holding AG announces lower net profit

Roche Holding AG, the Swiss health-care major, announced lower net profit after the earnings were weighed down by a strong Swiss franc and also incurring charges from one of its diagnostic units.

At the same time, the company reported that there has been growth in the company's overall... read more

Sanofi’s Phase-III Dengue Vaccine Efficacy Study Provides Promising Result

A phase-III dengue vaccine efficacy study carried out in five countries in Asia by French drug-maker Sanofi has revealed promising results. On Friday, Sanofi Pasteur division announced about the details of the phase, which have been published in the journal Lancet.

The efficacy against... read more

Atopic Dermatitis Treating Experimental Drug from Sanofi and Regeneron Shows Promising Results

Available drugs to treat atopic dermatitis, a chronic form of eczema, are not able to provide the desired effect. But soon, patients suffering from atopic dermatitis may be able to get relief as an experimental drug from Sanofi and Regeneron Pharmaceuticals Inc has shown reduction in skin... read more


Popular Stories

Overall childhood ‘asthma epidemic’ levels off in U.S.

The overall ‘asthma epidemic’ among children has... Read More

‘UC Quits’ Working to Help California Smokers Get Rid Of Smoking

As New Year is approaching, people have already... Read More

Scientists begin Stem Cell research to find cure for Alzheimer’s

Alzheimer’s disease, the commonest cause of... Read More

New House Bill to Restrict First-Time Opioid Prescriptions

Cases of opioid abuse have been increasing and... Read More

Comcast installs DOCSIS 3.1 modem on customer-facing network in Philadelphia

In an announcement made on December 22, cable giant... Read More